MoneyWorks4Me

Ajanta Pharma - Quaterly Results

28 Jul 2025 Evaluate
The company witnessed a 12.19% growth in the revenue at Rs. 12085.60 millions for the quarter ended June 2025 as compared to Rs. 10772.70 millions during the year-ago period.A slim rise of 8.02% was recorded in the Net profit for the quarter ended June 2025 to Rs. 2549.70  millions  From Rs. 2360.30 millions.Operating profit for the quarter ended June 2025 rose to 3700.30 millions as compared to 3442.00 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 12085.60 10772.70 12.19 12085.60 10772.70 12.19 43220.40 39711.20 8.84
Other Income 406.30 283.70 43.21 406.30 283.70 43.21 1198.70 1164.80 2.91
PBIDT 3700.30 3442.00 7.50 3700.30 3442.00 7.50 13245.90 12359.10 7.18
Interest 7.30 7.20 1.39 7.30 7.20 1.39 46.00 68.00 -32.35
PBDT 3693.00 3434.80 7.52 3693.00 3434.80 7.52 13199.90 12291.10 7.39
Depreciation 403.10 329.20 22.45 403.10 329.20 22.45 1399.30 1321.60 5.88
PBT 3289.90 3105.60 5.93 3289.90 3105.60 5.93 11800.60 10969.50 7.58
TAX 740.20 745.30 -0.68 740.20 745.30 -0.68 2631.70 2897.10 -9.16
Deferred Tax 32.90 31.10 5.79 32.90 31.10 5.79 51.40 121.30 -57.63
PAT 2549.70 2360.30 8.02 2549.70 2360.30 8.02 9168.90 8072.40 13.58
Equity 250.70 250.70 0.00 250.70 250.70 0.00 250.70 252.70 -0.79
PBIDTM(%) 30.62 31.95 -4.17 30.62 31.95 -4.17 30.65 31.12 -1.53
Peers
Company Name CMP
Sun Pharma. Inds. 1861.75
Dr. Reddys Labs. 1172.60
Cipla 1379.35
Lupin 2079.45
Zydus Lifesciences 1137.05
View more..